Evidence map›Paper›PMID 29066856›Full record

ArticleScientific reports2017

Modelling acrylamide acute neurotoxicity in zebrafish larvae.

Eva Prats, Cristian Gómez-Canela, Shani Ben-Lulu, Tamar Ziv, Francesc Padrós, Daniel Tornero, Natàlia Garcia-Reyero, Romà Tauler, Arie Admon, Demetrio Raldúa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Developmental and Neurotoxicity of Acrylamide to Zebrafish.International journal of molecular sciences · 2021
    Article
  13. Article
  14. Article
  15. Detection and Prioritization of Developmentally Neurotoxic and/or Neurotoxic Compounds Using Zebrafish.Toxicological sciences : an official journal of the Society of Toxicology · 2019
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Eva PratsCID-CSIC, Jordi Girona 18, 08034, Barcelona, Spain.ORCID 0000-0001-7838-2027
Cristian Gómez-CanelaIDAEA-CSIC, Jordi Girona 18, 08034, Barcelona, Spain.
Shani Ben-LuluThe Smoler Proteomics Center and the Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel.
Tamar ZivThe Smoler Proteomics Center and the Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel.
Francesc PadrósFish Diseases Diagnostic Service, Facultat de Veterinària. Universitat Autònoma de Barcelona, 08190, Bellaterra (Cerdanyola del Vallès), Spain.
Daniel TorneroIDAEA-CSIC, Jordi Girona 18, 08034, Barcelona, Spain.
Natàlia Garcia-ReyeroEnvironmental Laboratory-US Army Engineer Research and Development Center, Vicksburg, MS, USA.
Romà TaulerIDAEA-CSIC, Jordi Girona 18, 08034, Barcelona, Spain.
Arie AdmonThe Smoler Proteomics Center and the Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel.ORCID 0000-0003-0504-3950
Demetrio RaldúaIDAEA-CSIC, Jordi Girona 18, 08034, Barcelona, Spain. drpqam@cid.csic.es.ORCID 0000-0001-5256-1641
Consejo Superior de Investigaciones Científicas · ESTechnion – Israel Institute of Technology · ILCentro de Investigación y Desarrollo · ESUniversitat Autònoma de Barcelona · ESU.S. Army Engineer Research and Development Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acrylamide (ACR), a type-2 alkene, may lead to a synaptopathy characterized by ataxia, skeletal muscles weakness and numbness of the extremities in exposed human and laboratory animals. Currently, only the mildly affected patients undergo complete recovery, and identification of new molecules with therapeutic bioactivity against ACR acute neurotoxicity is urgently needed. Here, we have generated a zebrafish model for ACR neurotoxicity by exposing 5 days post-fertilization zebrafish larvae to 1 mM ACR for 3 days. Our results show that zebrafish mimics most of the pathophysiological processes described in humans and mammalian models. Motor function was altered, and specific effects were found on the presynaptic nerve terminals at the neuromuscular junction level, but not on the axonal tracts or myelin sheath integrity. Transcriptional markers of proteins involved in synaptic vesicle cycle were selectively altered, and the proteomic analysis showed that ACR-adducts were formed on cysteine residues of some synaptic proteins. Finally, analysis of neurotransmitters profile showed a significant effect on cholinergic and dopaminergic systems. These data support the suitability of the developed zebrafish model for screening of molecules with therapeutic value against this toxic neuropathy.

Indexed as

Models, BiologicalZebrafishAcrylamideAnimalsLarvaNeurotoxinsTranscription, GeneticAcrylamideNeurotoxins

Identifiers

PMID29066856
PMCPMC5655329
OpenAlexW2766168832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.